AI drug discovery

March 06, 2026 — Cambridge, Massachusetts, USA A significant milestone has been reached in AI-driven pharmaceutical development as Insilico...

March 08, 2026 — Cambridge, MA, USA The rapid integration of artificial intelligence in pharmaceutical research continues to reshape...

March 3, 2026 Insilico Medicine, a clinical-stage biotechnology company known for its generative artificial intelligence platforms, has launched a...

TOKYO, Feb. 13, 2026 — Nxera Pharma Co., Ltd. reported its consolidated financial and operational results for FY2025, outlining...

Agoura Hills, California — February 10, 2026: Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on oncology, immunotherapy, and...

CAMBRIDGE, Mass. & HOUSTON, Feb. 5, 2026 — Decoy Therapeutics, Inc., a preclinical-stage biotechnology company developing next-generation peptide conjugate...

Seattle and Vienna, January 20, 2026 — Parse Biosciences and Graph Therapeutics have announced a strategic partnership to create...

Cambridge, MA – December 3, 2025: Nona Biosciences has appointed Dr. Hongjiang Miao as its first Chief AI Officer,...

Miami, Florida – October 30, 2025 — Allosite Therapeutics, a biotechnology company pioneering allosteric integrin agonists for the treatment...

Dallas, Texas, October 30, 2025 — Lantern Pharma Inc. (NASDAQ: LTRN) announced it will present two cutting-edge AI-driven drug-development...